Clinical Trial Update: LR769 in Congenital Hemophilia Patients With Inhibitors Undergoing Elective Surgery or Invasive Procedures [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for LR769 in congenital hemophilia patients with inhibitors undergoing elective surgery or invasive procedures has completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• LR769

Snippet

Sponsor: Laboratoire français de Fractionnement et de Biotechnologies | Conditions: Hemophilia | Phase 3 | Status: COMPLETED | Results posted: 2019-09-06